BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36929451)

  • 1. Integration of clinical and spatial data to explore lipid metabolism-related genes for predicting prognosis and immune microenvironment in gliomas.
    Yu Z; Zhou Y; Li Y; Dong Z
    Funct Integr Genomics; 2023 Mar; 23(2):82. PubMed ID: 36929451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
    Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
    Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization.
    Zhang X; Sun X; Guo C; Li J; Liang G
    Am J Physiol Cell Physiol; 2024 Jan; 326(1):C252-C268. PubMed ID: 37982173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of m
    Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
    Front Immunol; 2022; 13():955848. PubMed ID: 36203569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas.
    Wang J; Xu L; Ding Q; Li X; Wang K; Xu S; Liu B
    Front Immunol; 2023; 14():1065062. PubMed ID: 37325664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
    Qi Y; Chen D; Lu Q; Yao Y; Ji C
    Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic power of a lipid metabolism gene panel for diffuse gliomas.
    Wu F; Zhao Z; Chai RC; Liu YQ; Li GZ; Jiang HY; Jiang T
    J Cell Mol Med; 2019 Nov; 23(11):7741-7748. PubMed ID: 31475440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients.
    Wang Y; Liu Y; Zhang C; Zhang C; Guan X; Jia W
    Front Immunol; 2022; 13():1028937. PubMed ID: 36389681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status.
    Zhou F; Shi Q; Fan X; Yu R; Wu Z; Wang B; Tian W; Yu T; Pan M; You Y; Wang Y
    Front Immunol; 2022; 13():841404. PubMed ID: 35265085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
    Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Qu S; Liu J; Wang H
    Front Immunol; 2021; 12():648416. PubMed ID: 33889156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
    Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
    BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy.
    Huang X; Sun Y; Song J; Huang Y; Shi H; Qian A; Cao Y; Zhou Y; Wang Q
    Front Immunol; 2023; 14():1301452. PubMed ID: 38045683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of EMT in Glioma and its Role in the Glioma Immune Microenvironment.
    Ning W; Qiu Z; Ji X; Wang X; An Y; Wang S; Zhang H
    J Mol Neurosci; 2020 Oct; 70(10):1501-1511. PubMed ID: 32495005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
    Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
    Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggrephagy-related gene signature correlates with survival and tumor-associated macrophages in glioma: Insights from single-cell and bulk RNA sequencing.
    Zhang X; Tan J; Zhang X; Pandey K; Zhong Y; Wu G; He K
    Math Biosci Eng; 2024 Jan; 21(2):2407-2431. PubMed ID: 38454689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.